EU drug regulator recommends clearing vaccine for monkeypox
The European Medicines Agency has said the smallpox vaccine made by Bavarian Nordic should also be authorised against monkeypox, as the outbreak of the once-rare disease continues to affect people across the continent.
The European Union drug regulator said its recommendation was based on animal studies that suggest the vaccine protects non-human primates from monkeypox. It is up to the EU’s executive arm, the European Commission, to approve the vaccine formally based on the EMA’s recommendation.
